Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-11-20
2007-11-20
Aulakh, Charanjit S. (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C549S408000, C549S407000, C549S398000
Reexamination Certificate
active
10522646
ABSTRACT:
A class of chromane and chromene compounds having the structure shown below and pharmaceutically acceptable salts thereof are useful as therapeutic compounds, particularly in the treatment and control of hyperlipidemia, hypercholesterolemia, dyslipidemia, and other lipid disorders, and in delaying the onset of or reducing the risk of conditions and sequelae that are associated with these diseases, such as atherosclerosis
REFERENCES:
patent: 4565882 (1986-01-01), Miyano et al.
patent: WO 02/26729 (2002-04-01), None
Abbott Laboratories, “Tricor® 48 mg and 145 mg (fenofibrate tablets)”, Prescribing Information, 1994.
Desai Ranjit C.
Sahoo Soumya
Aulakh Charanjit S.
Daniel Mark
McGinnis James L.
Merck & Co. , Inc.
LandOfFree
PPAR alpha selective compounds for the treatment of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with PPAR alpha selective compounds for the treatment of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and PPAR alpha selective compounds for the treatment of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3809454